B. Riley
http://www.brileyco.comB. Riley provides investment banking services to wide range of companies, as well as research and trading ideas to individual and institutional clients.
-
CytoSorbents Reports Record Second Quarter 2020 Financial Results
-
Cytosorbents (CTSO) Prices 5.26M Common Share Offering at $9.50/Sh
-
CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock
-
CytoSorbents Reports First Quarter 2020 Financial and Operational Results
-
CytoSorbents Announces 2019 Financial and Operational Results
-
CytoSorbents to Participate at the B. Riley FBR 20th Annual Institutional Investor Conference
-
CytoSorbents to Present at the B. Riley FBR Healthcare Conference and the H.C. Wainwright 20th Annual Global Investment Conference
-
CytoSorbents to Present at the 19th Annual B. Riley FBR Investor Conference
-
CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017
-
CytoSorbents Selected to Present at Special Operations SOMSA 2017 Conference and 18th Annual B. Riley & Co. Investor Conference
-
CytoSorbents 2017 - Propelling the Company to the "Next Level"
-
Cytosorbents (CTSO) Prices 2.22M Share Follow-On Offering at $4.50
-
CytoSorbents Announces Pricing of Follow-On Offering
-
CytoSorb® Q3 2016 Sales Reach Record $2.14M, Doubling From a Year Ago
-
B. Riley Starts CytoSorbents (CTSO) at Buy

